课题基金 / 基金详情

Extended Care Treatment of Multiple Risk Behaviors in Complex Patients

Extended Care Treatment of Multiple Risk Behaviors in Complex Patients
复杂患者多种危险行为的延伸护理治疗
批准号:
8263778
负责人:
Judith J. Prochaska
金额:
$24.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2015-05-31

项目摘要

项目成果

Judith J. Prochaska的其他基金

相似基金

相关文献

中文摘要
翻译
该中心的主题是药物滥用治疗的持续和延长护理模式,提供了更多 随着时间的推移,有机会满足患者更广泛的健康需求。危险行为往往会同时发生,而且 滥用酒精或其他药物的人可能会带来额外的风险,如吸烟、不良饮食、 缺乏体力活动,压力和痛苦,以及睡眠质量差。针对多个风险中的变化提供 增加健康福利、最大限度地促进健康和降低医疗成本的潜力。然而,争议 如何,甚至是否评估和治疗多种并存的情况 患者在场的人。分两个阶段进行,该集成组件将提供独特的 关于1200人的多重行为风险、健康功能和综合治疗需求的信息 在三个非常不同的护理系统中接受药物滥用治疗的客户:A县公共卫生丁丙诺啡 诊所,一个大型的非营利性综合管理医疗保健计划,以及一个退伍军人事务医疗中心。 在第一阶段,来自霍尔博士和韦斯纳博士的部件的900名参与者将完成一项健康风险 对16种行为的评估也评估了参与者的变化阶段。其主要目标是 检查:吸毒者中多种危险行为的流行率和改变的动机 治疗;多种危险行为与健康相关生活质量之间的关联; 风险行为的变化;以及18个月内与多种风险和变化相关的医疗成本 时间到了。研究结果将确定治疗需求,并确定第二阶段试点研究的干预目标。 第二阶段在随机对照的泰国试验和评估,一个创新的,在线的,延长护理, 计算机辅助和阶段性健康风险干预(S-HRI)--300名药物滥用参与者 治疗。S-人力资源研究所提供参与者对每个风险的变化阶段的反馈 就他们开始取得进展可以采取的最重要的一步提出建议。一个辅导员会 与参与者一起审查报告,并提供激励性面谈(ML)指导和推荐 相关的行为改变服务。干预参与者将完成S-HRI和ML-教练 在基线、3个月、6个月和12个月的随访时进行治疗。基本假设是,相对于通常的护理, 干预将带来更大的结果:(1)客户参与行为改变服务推荐,(2)行为 多重风险的变化,以及(3)在3、6、12和18个月时健康相关生活质量的改善 后续行动。第二个目标将检查成瘾治疗中的条件保留情况。
英文摘要
The theme of this Center, continuing and extended care models for drug abuse treatment, affords greater opportunity to address the broader health needs of patients over time. Risk behaviors tend to co-occur, and people who abuse alcohol or other drugs are likely to carry additional risks, such as tobacco use, poor diet, physical inactivity, stress and distress, and poor sleep quality. Targeting change in multiple risks offers the potential of increased health benefits, maximized health promotion, and reduced medical costs. Yet, controversies remain regarding how to, and even whether to, assess and treat the multiple comorbid conditions with which patients present. Proceeding in two phases, this Integrative component will provide unique information on the multiple behavioral risks, health functioning, and comprehensive treatment needs of 1200 clients in drug abuse treatment in three very different systems of care: a county public health buprenorphine clinic, a large non-profit integrated managed care health plan, and a Veteran's Affairs medical center. In Phase I, 900 participants from Drs. Hall's and Weisner's components will complete a health risk assessment of 16 behaviors that also assesses participants' stage of change. The primary aims are to examine: the prevalence of multiple risk behaviors and motivation to change among individuals in drug treatment; the association between multiple risk behaviors and health-related quality of life; covariation in changes in risk behaviors; and the medical costs associated with multiple risks and changes over 18-months time. Findings will identify treatment needs and prioritize intervention targets for the pilot study in Phase II. Phase II pilots and evaluates, in a randomized controlled thai, an Innovative, online, extended-care, computer-delivered and stage-tailored health risk intervention (S-HRI) with 300 participants in drug abuse treatment. The S-HRI provides feedback on participants' stages of change for each risk with recommendations on the single most important step they can take to begin progressing. A counselor will review the report with participants and provide motivational interviewing (Ml) coaching and referrals to relevant behavior change services. Intervention participants will complete the S-HRI and Ml-coaching sessions at baseline, 3, 6 and 12 months follow-up. Primary hypotheses are that, relative to usual care, the Intervention will result in greater: (1) client engagement with behavior change service referrals, (2) behavioral changes in multiple risks, and (3) improvements In health-related quality of life at 3, 6, 12, and 18 months follow-up. A secondary aim will examine retention In addictions treatment by condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
  • 批准号:
    8425043
  • 项目类别:
  • 资助金额:
    $35.78万
  • 财政年份:
    2009
  • 负责人:
    Judith J. Prochaska
  • 依托单位:
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: